Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Lancet Oncol. 2013 Jul 9;14(9):853–862. doi: 10.1016/S1470-2045(13)70253-5

Figure 1.

Figure 1

Kaplan-Meier curves of disease-specific survival for high-grade serous (HGSC) and endometrioid (EC) carcinomas, according to hormone receptor status. The data were left truncated to avoid potential survival bias from the inclusion of patients (<10%) enrolled >1 year after diagnosis, and right censored at 10 years. P-values correspond to log-rank tests of the equality of survivor functions across hormone receptor expression levels, stratified by study site.